Summary
The regional distribution of high affinity [33H]5-HT recognition sites in the brain of several vertebrates (pigeon, rat, mouse, guinea-pig, cat, dog, monkey and human) was analyzed using in vitro autoradiography. The presence of subtypes of 5-HT1 binding sites was investigated by selective displacements with 8-OH-DPAT, mesulergine and (±)SDZ 21-009 at appropriate concentrations to block 5-HT1A, 5-HT1c and 5-HT1B sites respectively. In addition, 5-HT1A, and 5-HT1c sites were directly visualized with the more selective radioligands [3H]8-OH-DPAT and [3H]mesulergine, respectively. In the pigeon brain, total [3H]5-HT binding sites were enriched in all telencephalic areas. Densely labelled regions were also present in the optic tectum and the brainstem. No binding was observed in the cerebellum. 8-OH-DPAT and mesulergine only displaced a small proportion of [3H]5-HT binding in most of the areas where high concentrations of 5-HT1 sites were found. (±)SDZ 21-009 did not affect [3H]5-HT binding in the regions examined. Taking into account our pharmacological studies, these results suggest that the majority of 5-HT1 sites belong to the 5-HT1D subtype in the pigeon brain. In the mammalian species investigated high levels of [3H]5-HT binding were found in the neo-cortex, hippocampal formation, basal ganglia and related structures (substantia nigra), raphe dorsalis, nucleus superior colliculus and choroid plexus. However, these brain areas were differentially enriched in subtypes of 5-HT1 recognition sites. 5-HT1A sites were observed in the neo-cortex, the hippocampal formation and the raphe nucleus, whereas 5-HT1C sites accounted for all 5-HT1 binding in the choroid plexus. In the mouse and rat brain, 5-HT1B binding sites were enriched in the basal ganglia and associated regions (substantia nigra). These areas were enriched in 5-HT1D sites in the brain of the other mammals studied. In these animals, no site with a 5-HT1B pharmacological profile were detected.
These results indicate that 5-HT1A 5-HT1c and 5-HT1D sites are present already in the lower vertebrate species investigated and that 5-HT1B appear to be exclusive of the myomorph rodents (mouse, rat). Furthermore, the different subtypes of the 5-HT1, receptors present a conserved regional distribution with the 5-HT1D sites being enriched in the basal ganglia and the 5-HT1A sites predominating in the hippocampal formation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bouhelal R, Smounya L, Bockaert J (1988) 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. Eur J Pharmacol 151:189–196
Brauth SE, Kitt CA (1980) The palcostriatal system of Caiman crocodilus. J Comp Neurol 189:437–465
Brauth SE, Fergusson JL, Kitt CA (1978) Prosencephalic pathways related to the paleostriatum of the pigeon (Columbia Livia). Brain Res 147:205–221
Campos MF, Rodrigues FC (1987) Rats and marmosets respond differently to serotonin agonists and antagonists. Psychopharmacology 92:478–483
Dietl MM, Palacios JM (1988) Receptor autoradiography as a tool for the study of the phylogeny of the basal ganglia. J Receptor Res 8:521–532
Engel G, Göthert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332:1–7
Galzin AM, Blier P, Chodkiewicz JP, Poirier MF, Loo H, Roux FX, Redondo A, Lista A, Ramdine R, Langer SZ (1988) Pharmacological characterization of the serotonin 5-HT autoreceptor modulating the electrically-evoked release of 3H-5-HT from slices of human frontal cortex. Soc Neurosci vol 14:129.7 (Abstracts)
Gerschenfeld HM, Paupardin-Tritsch D (1974) Ionic mechanisms and receptor properties underlying the responses of molluscan neurones to 5-hydroxytryptamine. J Physiol (Lond) 243:427–456
Heuring RE, Schlegel JR, Peroutka SJ (1986) Species variations in RU 24969 interactions with non 5-HT1A binding sites. Eur J Pharmacol 122:279–282
Hoyer D, Engel G, Kalkman HO (1985a) Characterization of the 5-HT1B recognition site in rat brain: binding studies with (−) [125I]iodocyanopindolol. Eur J Pharmacol 118:1–12
Hoyer D, Engel G, Kalkman HO (1985 b) Molecular pharmacology of 5-HT1B, and 5-HT2 recognition sites in rat and pig brain membranes: Radioligand binding studies with [3H]5-HT, [3H]8 OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserine. Eur J Pharmacol 118:13–23
Hoyer D, Pazos A, Probst A, Palacios JM (1986) Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376:85–96
Jonsson G (1981) Lesion methods in neurobiology in: Heym C, Forssmann W-G (eds) Techniques in neuroanatomical research. Springer, Berlin Heidelberg New York, pp 71–99
Middlemiss DN, Bremer ME, Smith SM (1988) A pharmacological analysis of the 5-HT receptors mediating inhibition of 5-HT release in the guinea-pig frontal cortex. Eur J Pharmacol 157:101–107
Murphy TL Bylund DB (1988) Oxymetazoline inhibits adenylate cyclase by activation of serotonin-1 receptors in the OK cell, an established renal epithelial cell line. Mol Pharmacol 34:1–7
Oberlander C, Blaquière B, Pujol J-F (1986) Distinct functions for dopamine and serotonin in locomotor behavior: evidence using the 5-HT1, agonist RU 24969 in globus pallidus-lesioned rats. Neurosci Lett 67:113 -118
Palacios JM, Died MM (1989) Autoradiographic studies on 5-HT receptors in: Sanders-Bush (ed) The serotonin receptors. The Humana Press Inc, Clifton New Jersey, pp 89–138
Palacios JM, Pazos A, Hoyer D (1987) Characterization and mapping of 5-HTIA sites in the brain of animals and man. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors, Horwood, Chichester, pp 67–81
Parent A (1973) Demonstration of a catecholaminergic pathway from the midbrain to the strioamygdaloid complex in the turtle (Chrysemys Picta). J Anat 114:379–387
Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain 1: Serotonin-1 receptors. Brain Res 346:205–230
Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in the human brain III Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21:97–122
Pazos A, Hoyer D, Died MM, Palacios JM (1988) Autoradiography of serotonin receptors. In: Osborne NN, Hamon M (eds) Neuronal serotonin. Wiley, New York, p 507–543
Peroutka SJ (1988) 5-hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization. TINS 11:496–500
Quirion R, Richard J (1987) Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin type 1 receptors in rat brain. Synapse 1:124–130
Reiner A, Brauth SE, Karten HJ (1984) Evolution of the amniote basal ganglia. TINS 7:320–325
Schlicker E, Fink K, Betz R, Göthert M (1988) The serotonin autoreceptor in the pig brain cortex belongs to the 5-HTID receptor subtype. Naunyn-Schmiedeberg's Arch Pharmacol 338 (suppl): R67
Schnellmann RG, Waters SJ, Nelson DL (1984) [3H]5-hydroxytryptamine binding sites: species and tissue variations. J Neurochem 42:65–70
Schoeffter P, Waeber C, Palacios JM, Hoyer D (1988) The 5hydroxytryptamine 5-HTID receptor is negatively coupled to adenylate cyclase in rat substantia nigra. Naunyn-Schmiedeberg's Arch Pharmacol 337:602–608
Schwarcz R, Bennett JP, Coyle JT (1977) Loss of striatal serotonin synaptic receptor binding induced by kainic acid lesions: correlations with Huntington's disease. J Neurochem 28:867–869
Schwartz JH, Shkolnik LJ (1981) The giant serotoninergic neuron in Aplysia: a multi-targeted nerve cell. J Neurosci 1:606–619
Seuwen K, Magnaldo I, Pouysségur J (1988) Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HTIB receptors coupled to a Gi-protein. Nature 335:254–256
Smeets WJAJ, Hoogland PV, Voorn P (1986) The distribution of dopamine immunoreactivity in the forebrain and midbrain of the lizard Gekko gecko: an immunohistochemical study with antibodies against dopamine. J Comp Neurol 253:46–60
Smith GN, Hingtgen J, DeMyer W (1987) Serotonergic involvement in the backward tumbling response of the parlor tumbler pigeon. Brain Res 400:399–402
Waeber C, Schoeffter P, Palacios JM, Hoyer D (1988 a) Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 337:595–601
Waeber C, Died MM, Hoyer D, Probst A, Palacios JM (1988b) Visualization of a novel serotonin recognition site (5-HT1D) in the human brain by autoradiography. Neurosci Lett 88:11–16
Waeber C, Schoeffter P, Palacios JM, Hoyer D (1989) 5-HT1D receptors in guinea-pig and pigeon brain: radioligand binding and biochemical studies. Naunyn-Schmiedeberg's Arch Pharmacol 340:479–485
Waeber C, Palacios JM (1989) Serotonin-1 receptors in the human basal ganglia are decreased in Huntington's chorea but not in Parkinson's disease. Neuroscience (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waeber, C., Died, M.M., Hoyer, D. et al. 5.HT1 receptors in the vertebrate brain. Naunyn-Schmiedeberg's Arch Pharmacol 340, 486–494 (1989). https://doi.org/10.1007/BF00260602
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00260602